NeuroPace Inc Income Statement
NPCE|5 years of annual SEC 10-K data (FY2021-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
NeuroPace Inc reported $80M in revenue and $27M in net loss for FY2025. Revenue has grown at a 18.1% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $79.9M | $65.4M | $45.5M | $45.2M | $41.1M |
| Cost of Revenue | $20.8M | $17.3M | $13.0M | $11.7M | $10.9M |
| Gross Profit | $59.1M | $48.1M | $32.5M | $33.4M | $30.3M |
| SG&A Expense | $17.4M | $54.5M | $51.3M | $39.0M | $27.6M |
| R&D Expense | $23.7M | $20.8M | $21.9M | $18.2M | $15.7M |
| Operating Income | -$21.7M | -$27.2M | -$40.8M | -$23.7M | -$13.1M |
| Interest Expense | - | - | $7.5M | $7.4M | $11.5M |
| Income Tax | $0 | - | - | - | - |
| Net Income | -$27.1M | -$33.0M | -$47.1M | -$36.1M | -$24.3M |
| EPS (Basic) | -$0.93 | -$1.27 | -$1.91 | -$2.17 | -$117.85 |
| EPS (Diluted) | -$0.93 | -$1.27 | -$1.91 | -$2.17 | -$117.85 |
| Shares Outstanding | 30.1M | 27.8M | 25.0M | 24.5M | 314.1K |
| Gross Margin | 73.9% | 73.6% | 71.4% | 74.0% | 73.6% |
| Operating Margin | -27.1% | -41.5% | -89.6% | -52.5% | -31.7% |
| Profit Margin | -34.0% | -50.4% | -103.4% | -79.8% | -59.0% |